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Abstract
The Inhibitor of Growth (ING) proteins represent a type II tumor suppressor family comprising five conserved
genes, ING1 to ING5. While ING1, ING2 and ING3 proteins are stable components of the mSIN3a-HDAC complexes,
the association of ING1, ING4 and ING5 with HAT protein complexes was also reported. Among these the ING1
and ING2 have been analyzed more deeply. Similar to other tumor suppressor factors the ING proteins are also
involved in many cellular pathways linked to cancer and cell proliferation such as cell cycle regulation, cellular
senescence, DNA repair, apoptosis, inhibition of angiogenesis and modulation of chromatin.
A common structural feature of ING factors is the conserved plant homeodomain (PHD), which can bind directly to
the histone mark trimethylated lysine of histone H3 (H3K4me3). PHD mutants lose the ability to undergo cellular
senescence linking chromatin mark recognition with cellular senescence. ING1 and ING2 are localized in the cell
nucleus and associated with chromatin modifying enzymes, linking tumor suppression directly to chromatin
regulation. In line with this, the expression of ING1 in tumors is aberrant or identified point mutations are mostly
localized in the PHD finger and affect histone binding. Interestingly, ING1 protein levels increase in replicative
senescent cells, latter representing an efficient pathway to inhibit cancer proliferation. In association with this,
suppression of p33ING1 expression prolongs replicative life span and is also sufficient to bypass oncogene-induced
senescence. Recent analyses of ING1- and ING2-deficient mice confirm a tumor suppressive role of ING1 and ING2
and also indicate an essential role of ING2 in meiosis.
Here we summarize the activity of ING1 and ING2 as tumor suppressors, chromatin factors and in development.
Association of ING factors with cellular
senescence
The ING proteins are evolutionary conserved factors
with orthologs identified from yeast to human [1]. In
mouse and human the five different ING loci are distrib-
uted over the genome, most of which give rise to multi-
ple protein products as a consequence of alternative
splicing events [2]. The ING1 gene harbors three exons
and can be alternatively spliced to generate p47ING1a,
p33ING1b, p27ING1d, and p24ING1c in human [2].
Among these isoforms p33ING1b is the most widely
expressed in human tissues. Mouse ING1 was found to
h a v et h r e es p l i c ev a r i a n t s ,p 3 1 I N G 1 a ,p 3 1 I N G 1 ca n d
p37ING1b [3]. So far identified, ING2 encodes two iso-
forms, ING2a (p33ING2) and ING2b [4].
Decreased ING1 expression or loss of heterozygosity
of the ING1 locus have been observed in various
tumors, including breast, ovarian, head carcinomas and
melanoma [5,6]. Also, ING2 displays reduced expression
levels in different tumors, including lung cancer and
melanoma [6].
The role of ING1 and ING2 as tumor suppressor pro-
teins is supported since both factors are involved in cel-
lular senescence, an effective anti-tumor pathway.
Senescent cells are characterized by a stable and irrever-
sible cell cycle arrest, frequently in the G0/G1 phase of
the cell cycle [7]. Although they do not divide, senescent
cells are viable, metabolically active and do not engage
in programmed cell death (apoptosis) [7]. The senescent
phenotype can be induced by a variety of stimuli. Repli-
cative senescence is presumably triggered by telomere
shortening, whereas premature senescence can be acti-
vated in response to a variety of stress signals, including
overexpression of oncogenes such as Ras or e.g. oxida-
tive DNA damage [7,8].
Many signaling pathways are responsible for the
implementation and maintenance of the senescent
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any medium, provided the original work is properly cited.phenotype caused by different stimuli, including changes
in expression levels of Cyclin D1, c-Myc-Bmi, promyelo-
cytic leukemia protein (PML), p53 or retinoblastoma
protein (pRb) [2]. Cellular senescence is accompanied by
specific epigenetic changes which play an important role
in regulation of gene expression and appearance of het-
erochromatic domains known as senescence-associated
heterochromatic foci (SAHFs) [9,10].
First evidence for ING1 to be involved in cellular
senescence was shown by RNA and protein levels of
p33ING1 that were 8- to 10-fold higher in senescent
cells compared to young, proliferation-competent
human diploid fibroblasts [11]. Accordingly, expression
of antisense ING1 R N Ar e s u l t e di na ne x t e n s i o no f
replicative life span of normal human fibroblasts, sug-
gesting an important role for p33ING1 in the initiation
of replicative senescence [11]. In addition, ectopic
expression of p33ING1 in primary human fibroblasts
resulted in growth arrest with an expression of senes-
cence-specific markers, e.g. senescence-associated b-
galactosidase activity [12]. Furthermore, it was shown
that p33ING1 mRNA-level was up-regulated in senes-
cent human prostate epithelial cells [13]. In line with
this, inactivation of p33ING1 promoted neoplastic trans-
formation [14]. Other reports concerning the isoform
p47INGa have shown that the protein level of p47INGa
increased during replicative senescence of human fibro-
blasts [15]. In addition, transient overexpression of the
p47ING1a isoform was able to induce a senescent phe-
notype in the same cell type [15]. Taken together, these
observations suggest that both isoforms can play a role
in the implementation of replicative senescence.
Studies concerning oncogene-induced senescence
revealed that suppression of p33ING1 by RNA-interfer-
ence in human fibroblasts was sufficient to bypass onco-
gene-induced senescence [16]. In line with this,
p33ING1 protein level was increased in senescent
human fibroblasts, whereas p47ING1a protein levels did
not change [17]. These observations suggest an impor-
tant role for p33ING1 in the implementation of onco-
gene-induced senescence.
Analyses of mouse embryonic fibroblasts (MEFs) which
exhibited a reduced expression of all murine ING1 tran-
scripts showed impaired induction of senescence trig-
gered by oncogenic stress [18]. This also supports a role
for the Ing1 locus as a critical mediator of the oncogene-
induced senescence. In contrast, p37ING1-deficient but
p31ING1-expressing MEFs did not exhibit an altered
oncogene-induced senescence in comparison to wildtype
MEFs [19]. This suggests that the ING1 isoforms might
have specific roles in the implementation of oncogene-
induced senescence in MEFs.
There is also a functional link of ING proteins to p53
in senescence as regulators of p53 protein stability and
posttranslational modification [2,20]. An increase of p53
transcriptional activity can also be associated with cellu-
lar senescence [21]. Recently, it has been shown that
human fibroblasts with a disabled p53 pathway and
enforced p33ING1b expression failed to trigger effi-
ciently cellular senescence [16], suggesting that the
implementation of cellular senescence by p33ING1
requires an intact p53 pathway.
However, studies analyzing ING1-deficient MEFs indi-
cated p53-independent pathways of ING1-mediated cel-
lular senescence [19,22]. Taken together, these results
suggest that the link between ING1 and p53 in the
implementation of cellular senescence might be cell type
specific.
Interestingly, human fibroblasts transfected with
p33ING1 carrying point mutations in the PHD, which
led to deficient H3K4me3 binding, were not able to
undergo cellular senescence[ 1 6 ] .T h i ss t r e n g t h e n st h e
role of ING1 as tumor suppressor and suggests an
important role of the PHD and chromatin in regulation
of cellular senescence (Figure 1). Notably, p33ING1 was
found to accumulate on chromatin in oncogene-induced
senescent human fibroblasts, but is excluded from
S A H F sa si tw a sa l s of o rt h eh i s t o n em a r kH 3 K 4 m e 3
[16]. This supports a critical role of ING1 protein in the
induction of cellular senescence, whereas it remains to
be shown whether ING1 is required for maintenance of
the irreversible cellular senescence status.
The role of ING2 in the regulation of cellular senes-
cence indicates a more complex situation. Overexpres-
sion of ING2 in early passage human fibroblasts led to
an induction of premature senescence in a p53-depen-
dent fashion, whereas knockdown of ING2 with a small
interfering RNA construct delayed onset of replicative
senescence in these cells. In high passaged cells, an
increased p33ING2 expression has been reported [23].
However, other in vitro studies analyzing cellular senes-
c e n c es u g g e s taf u n c t i o n a li n t e r p l a yo fI N G 2w i t ht h e
p53 tumor suppressor in two different manners. Down-
regulation of ING2 in human telomerase reverse tran-
scriptase (hTERT)-immortalized human fibroblasts by
small interfering RNA was associated with a senescence-
like arrest, which occurred in a p53-independent man-
ner. In contrast, overexpression of ING2 was found to
induce a p53-dependent senescence pathway [24]. The
different observations might be linked to the different
cell types and noteworthy may link hTERT expression
to ING2 activity.
Interestingly, analyses of the ING2-isoforms, demon-
strated different expression levels of ING2a and ING2b
in human fibroblasts undergoing replicative senescence.
It was found that the expression level of the ING2-iso-
form, ING2a, which is closely related to p33ING1, was
down-regulated in a p53- dependent manner in these
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sion level of the shorter isoform ING2b was not chan-
ged in senescent cells in comparison to the expression
level in young human fibroblasts [25]. This indicates
that the expression of ING2a and ING2b might be dif-
ferentially regulated and be important in determining
cell fate.
Association of ING1 and ING2 with chromatin
p33ING1 and ING2 are purified as stable components
o ft h eS A P 3 0-m S I N 3 ah i s t o n ed e a c e t y l a s e( H D A C )
complexes and are also shown to be associated with
brahma-related gene 1 (Brg1)-based SWItch/Sucrose
NonFermentable (SWI/SNF) chromatin remodelling
complexes [26,27].
The abilities to bind to histone marks and to modify
histones are significant features of ING proteins. The
conserved PHD of ING1 and ING2 binds to histone 3
di- or trimethylated at lysine 4 (H3K4me2, H3K4me3)
which is a histone mark associated with activated and
open chromatin [28]. The binding of the PHD to
H3K4me2/3 was shown to occur after genotoxic stress
and in response to DNA damage. Mutations within the
PHD prevent this interaction and are associated with
reduced DNA repair after UV-irradiation or promote
DNA-damage induced apoptosis in melanoma cells
[29,30]. The PHD of ING1 and ING2 is also associated
with a histone methyl transferase activity (HMT) that
methylates histones H1 and H3 residues, within histone
H3 residues the first 20 amino acids, however excluding
the common methyl acceptor sites lysine 4 and lysine 9
[31].
Furthermore, the N-termini of ING1 and ING2
directly interact with Sin3A-associated protein (SAP30),
a component of the Sin3 homolog A/HDAC (Sin3A/
HDAC) repressor complex [32] linking HMT and
Figure 1 The functional role of the ING- Plant Homeodomain (PHD). The role of the PHD was analyzed by mutations of this domain. The
PHD is essential for binding to histone H3 at trimethylated lysine 4, the induction of cellular senescence and tumor suppression.
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This also suggests that the interaction of the PHD to
H3K4me2/3 stabilizes the Sin3A/HDAC repressor com-
plex at the nucleosomes for the deacetylation of histone
residues linking DNA repair, apoptosis and tumorigenic
functions with chromatin regulation and gene transcrip-
tion [32].
Interestingly, binding assays in HeLa cells have shown
that p33ING1 and ING2 also recruit Sirtuin1 (SIRT1) to
the Sin3A/HDAC complex [33]. SIRT1 uses Nicotina-
mide adenine dinucleotide (NAD+) as a cofactor provid-
ing a possible link between metabolic pathways and
epigenetic control [34].
The interaction between ING1 and the Sin3A/HDAC
complex plays also an important role in the maintenance
of genome stability in mammalian cells [35,36]. Studies
by Xin et al. (2004) in HeLa cells showed that p33ING1
interacts with Sin3A/HDAC complex and the DNA
methyltransferase 1 -associated protein 1 (DMAP1) to
maintain hypoacetylation and histone methylation in
pericentric heterochromatin during late S phase of the
cell cycle [35,36]. Taken together, these results indicate
that ING proteins are involved in cellular processes con-
necting histone deacetylation, histone methylation, and
DNA methylation in maintaining pericentric heterochro-
matin structure throughout cell divisions [37].
Another link to gene repression was revealed by find-
ings that ING1 and ING2 interact with the corepressor
Alien in vitro and in vivo [2,38]. Alien is a corepressor
for certain nuclear hormone receptors and was also
found as a corepressor for cell cycle regulator E2F1,
inhibiting its transcriptional activity [39,40]. Interest-
ingly, Alien binds Sin3A as well and mediates gene
silencing in part by the recruitment of HDAC activity
[39]. The interaction with ING1 and ING2 was shown
to enhance the Alien-mediated gene repression [38].
Thus, ING1 and ING2 bind to methylated histone H3
and recruit HDAC and HMT activity associated with
gene repression.
Interestingly, other studies showed an ING1 isoform
specific interaction with histone acetyl transferases
(HATs). The interaction of p33ING1 with HATs was
shown to lead to a hyperacetylation of histones H3 and
H4, whereas the p47ING1 isoform inhibits acetylation of
these histones H3 and H4 [2,41,42]. In addition,
p33ING1 seems to play a tethering role between p300
and proliferating cell nuclear antigen (PCNA) facilitating
their physical functions, p300-mediated chromatin remo-
delling and PCNA function in DNA repair. Studies
revealed that p33ING1b is complexed with both p300
and PCNA [41]. The ING1-PCNA interaction was
observed following DNA damage after UV-irradiation. In
contrast, ING1 mutants lacking the PCNA interaction
failed to induce apoptosis after UV-irradiation. This may
suggest that the ING1-PCNA-HAT interaction may
occur in cells in stress-mediated apoptosis induction [41].
Moreover, ING2 also interacts with HATs leading to a
p300-mediated p53 acetylation, which results in an
active p53 state, although ING2 cannot directly bind to
p53 [23,43]. This suggests that ING2 initiates an
enhanced binding of p53 to p300, acting as a cofactor
for p300-mediated p53 acetylation [23,43]. The ING1
and p53 interaction may be involved in DNA repair and
genome stability. After UV-irradiation ING2 mediates
the recruitment of the damage-recognition Xeroderma
pigmentosum group A-complementing (XPA) protein to
the photo-lesion site. In line with this, ING2-knockdown
suggests ING2 as an essential factor for the nucleotide
excision repair. Thus, ING2 seems to negatively regulate
cell proliferation through activation of p53 by enhancing
its acetylation and is required for the initial DNA
damage sensing and chromatin regulation in the nucleo-
tide excision repair process [44].
Developmental role of ING1 and ING2
The developmental and physiological functions of ING1
and ING2 in vivo have been investigated by manipulat-
ing endogenous ING genes. Several mouse models with
deficiency in the ING1 locus have been described
[19,22]. Mouse ING1 was found to have three splice var-
iants, p31ING1a, p31ING1c and p37ING1b [3]. Kichina
et al. (2006) used gene targeting embryonic stem cells
t og e n e r a t eI n g 1 - n u l lm i c e .T h e s em i c ew e r ev i a b l ea n d
approximately 20% smaller in size compared to their
wild-type littermates. Notably, the Ing1-null mice were
more prone to effects of whole body irradiation. Inter-
estingly, while none of the age-matched wild-type litter-
mates developed B-cell lymphoma, a significant number
of aged ING1 knock-out mice developed this type of
tumor. Consistent with this observation, mice deficient
for specifically the p37ING1 predominant isoform also
developed spontaneous follicular B-cell lymphoma [19].
This indicates that the p37ING1 isoform may play a
role in the suppression of B-cell lymphoma in vivo,
which is in line with the role of ING1 as a tumor
suppressor.
Moreover, the role of ING1 expression patterns in
mammalian development was analyzed in 12.5-day
mouse embryos. These observations suggest a possible
involvement of ING1 in developmental regulated apop-
tosis because high levels of ING1 were observed in
regions, which are known for increased apoptosis during
embryogenesis [45].
It is noteworthy that studies of Coles et al. (2007) and
Kichina et al. (2006) suggest no correlation between p53
and ING1 proteins, indicating a p53-independent role
for ING1 in the regulation of cell growth and apoptosis
in vivo.
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that not all ING-mediated functions are redundant. The
developmental and physiological functions of ING2
through targeted germline disruption suggest that
ING2-deficient mice exhibited a normal body size [46],
whereas ING1-deficient mice were smaller compared to
the wild-type mice [22]. Interestingly, loss of ING2
resulted in an elevated incidence of soft-tissue sarcomas,
while ING1-deficient mice preferentially developed B-cell
lymphomas, supporting the role of ING proteins as tumor
suppressors [22,46]. ING2 expression was abundant in
testes of normal mice and the testes of ING2-deficient
mice showed a degeneration of seminiferous tubules and
meiotic arrest before pachytene stage with incomplete
meiotic recombination. Consequently, this defect in sper-
matogenesis of ING2-deficient mice led to male infertility
indicating an essential role for ING2 in meiosis [46]. On
the other hand, ING1 expression was low in testes [47]
and ING1-deficient mice seemed not to exhibit any
abnormalities in spermatogenesis and were fertile [22].
Taken together, these studies provide evidences that endo-
genous ING1 and ING2 seem to have diverse functions in
tumor suppression and spermatogenesis.
Conclusions
ING1 and ING2 are interesting factors due to their role
in a battery of cellular protective pathways. This seems
to be mediated by interaction with other cellular factors.
An important role seems to be mediated by the PHD,
which links histone H3K4me3 to ING-regulated path-
ways. However, the detailed roles of ING1 and ING2
are not fully solved yet. It is unclear whether ING fac-
tors are required only for induction of cellular senes-
cence or also for its maintenance. It is also unclear
under which control ING interacts in a pathway-specific
manner with other factors. Also, the posttranslational
modifications of ING that have regulatory roles require
to be addressed. The potential redundant roles of ING1
and ING2 on developmental level will provide further
insights by generating double null mutants.
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